FiercePharma says: Lilly posted $941.8 million in third-quarter net income, way up from last year's $465.6 million loss on charges. More impressively, however, the company managed to boost sales by 6.8 percent during a quarter when its rivals had a tough time on the revenue side.. Read more of our coverage here... [2]
Highlights:
Check out Lilly's current earnings estimates from CNN Money [3]
Lilly's Website: http://www.lilly.com/ [4]
Related Articles:
Lilly juggles jobs for emerging-markets growth
[5]Cost-conscious Medco pits Plavix against Effient
[6]Lilly's promo deal with CVS draws fire
[7]Lilly offloads 700-worker Indiana plant [8]
[9]
Links:
[1] http://www.fiercebiotech.com/press-releases/lilly-reports-solid-third-quarter-2009-results-revises-full-year-2009-eps-guidance-0
[2] http://www.fiercepharma.com/story/lilly-gilead-impress-q3-sales-growth/2009-10-21
[3] http://money.cnn.com/quote/estimates/estimates.html?symb=LLY
[4] http://www.lilly.com/
[5] http://www.fiercepharma.com/story/lilly-juggles-jobs-emerging-markets-growth/2009-10-22
[6] http://www.fiercepharma.com/story/cost-conscious-medco-pits-plavix-against-effient/2009-10-20-0
[7] http://www.fiercepharma.com/story/lillys-promo-deal-cvs-draws-fire/2009-10-19
[8] http://www.fiercepharma.com/story/lilly-offloads-700-worker-indiana-plant/2009-10-15
[9] http://www.fiercepharma.com/story/j-j-rep-says-he-promoted-risperdal-label/2009-10-30
[10] http://www.fiercepharma.com/special-reports/abbott-q3-results-q3-top-pharma-company-earnings-reports
[11] http://www.fiercepharma.com/special-reports/q3-top-pharma-company-earnings-reports
[12] http://www.fiercepharma.com/special-reports/amgen-q3-results-q3-top-pharma-company-earnings-reports